Apervita, Diameter Health join forces to improve data quality for value-based care contracting
Health IT company Apervita will leverage Diameter Health s capabilities which include cleaning and enriching clinical data to enhance data quality for stakeholders looking to create value-based care contracts.
Shares1
A new health IT partnership aims to improve clinical data quality and thereby increase the volume of data available for care quality measurement.
The partnership will combine Chicago-based Apervita and Farmington, Connecticut-based Diameter Health’s expertise to provide payers, providers and other healthcare stakeholders with access to clean clinical data for value-based care delivery, said Rick Howard, Apervita’s chief product officer, in an email.
Share this article
Share this article
LAGUNA HILLS, Calif., March 3, 2021 /PRNewswire/ Spineart USA Inc. announced today that clinical principal investigator, Dr. Domagoj Coric at Carolina Neurosurgery and Spine Associates in Charlotte NC, performed the first surgery in the two-level U.S. Investigational Device Exemption (IDE) Clinical Trial of the BAGUERA®C Cervical Disc Prosthesis. The BAGUERA®C implant is an investigational device designed to reconstruct the cervical disc. The goal of this surgery is to restore the height and preserve motion at that spinal level.
(PRNewsfoto/Spineart USA Inc.) The BAGUERA®C cervical disc is a modern generation artificial disc and the technique is straightforward compared to other devices I have used. I am excited to continue enrolling more patients and to start collecting outcome data, said Dr. Coric, Principal Investigator at Carolina Neurosurgery and Spine Associates.
Many players in life sciences and other sectors balk at updating their compliance systems because of the cost and resources involved, but addressing possible lapses now can save your company millions of dollars in fines and reputational damage.
President Biden used the Defense Production Act to direct Merck to convert two of its facilities into production sites for Johnson & Johnson's Covid-19 vaccine. In addition, he said J&J will run its own vaccine production sites 24/7.
MedCity News
Could AI reduce healthcare waste? Approach of online retailers could provide clues
Just as Amazon leverages machine learning to develop valuable insights into consumer purchasing behavior in real time, healthcare organizations can strengthen their ability to reduce costs of care and eliminate waste and abuse with this type of intelligence.
Shares0
When Amazon envisioned Alexa, an AI-powered, voice-activated customer recommendation system, it was a feat that required machine learning and massive amounts of data to provide answers to conversational queries quickly, even in a noisy environment. Now, the same data analysis capabilities that enable Amazon to become hyper-familiar with consumer purchasing patterns could hold the key to reducing waste in healthcare.